ResMed Announces Participation in the 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

ResMed (NYSE: RMD) announced that CEO Mick Farrell will present at the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021, at approximately 4:30 PM EST via webcast. The conference will provide insights into ResMed's innovative digital health technologies and cloud-connected medical devices, aimed at treating chronic diseases like sleep apnea and COPD. The audio-only webcast replay will be available about an hour after the presentation and remain accessible for 30 days.

Positive

• CEO Mick Farrell will present at a prestigious healthcare conference, enhancing corporate visibility.
• Focus on innovative solutions for chronic diseases highlights ResMed's industry leadership.

Negative

• None.

ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the 39^th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021, beginning at approximately 4:30 p.m. (Eastern Standard Time) via webcast.

More information about this event, including access to the live, audio-only webcast, may be accessed by visiting http://investor.resmed.com. Conference attendees will be able to access the video webcast via the J.P. Morgan Digital Conference Book. The audio-only webcast replay will be available approximately one hour after the live webcast ends and will be accessible for approximately 30 days following the conference.

About ResMed

At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210105005330/en/

FAQ

When will ResMed's CEO present at the J.P. Morgan Healthcare Conference?

Mick Farrell will present on January 12, 2021, at approximately 4:30 PM EST.

What is the focus of ResMed's presentation at the conference?

The presentation will showcase ResMed's innovative digital health technologies for treating chronic diseases.

How can investors access ResMed's conference presentation?

Investors can access the live webcast via ResMed's investor relations website.

How long will the recorded webcast of ResMed's presentation be available?

The audio-only webcast replay will be available for approximately 30 days after the live event.